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Results: The results showed that treatment of BNP postconditioning could signiﬁ-
cantly decrease the infarct size and the levels of LDH and CK after 4-h reperfusion (all
P<0.05). BNP postconditioning could also signiﬁcantly inhibit the increases of TNF-
a and IL-6 (both P<0.05). In addition, BNP postconditioning could signiﬁcantly
inhibit HMGB1 expression induced by I/R (P<0.05). Administration of LY294002
abolished the effects of BNP postconditioning on myocardial I/R injury and the ex-
pressions of phospho-Akt and HMGB1 (all P<0.05).
Conclusions: Conclusion: The present study suggests that postconditioning of BNP
could protect against myocardial I/R injury which may be associated with inhibiting
HMGB1 expression, while PI3K/Akt signaling pathway may be involved in the
expression of HMGB1 and the protective effect of BNP postconditioning.
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Objectives: Systemic vasospasm is the fundamental pathological features of pre-
eclampsia, but the mechanism is unclear. Based on the previous studies that there
existed high titers of angiotensin II (ANG II) type 1 receptor (AT1R) autoantibodies
(AT1-AA) in preeclamptic patients, current study aims to discover whether or not
puriﬁed AT1-AA from sera of preeclamptic patients could cause sustained activation
of AT1R on thoracic aortic vascular smooth muscle. If that were the case, molecular
mechanisms of reduced desensitization of AT1R were further explored.
Methods: Afﬁnity chromatography method was used to purify AT1-AA from serum
of 51 preeclampsia patients and negative IgG from serum of 44 normal pregnant
women. Experimental groups are as follows: AT1-AA group (210-6mmol/L);
negative IgG group (210-6mmol/L); ANG II group (210-6mmol/L); losartan (LST)
group (210-6mmol/L AT1-AA+210-5mmol/L LST). In vitro vascular ring tech-
nology was performed to observe the inﬂuence of different treatments on the vascular
tone of rat thoracic aorta; Primary cultured rats’ vascular smooth muscle cells
(VSMCs) were used to detect intracellular calcium ﬂuorescence intensity variance
among different groups under laser scanning confocal microscope; After AT1R-
pcDNA3.1 plasmids were transiently transfected into HEK293 cells, endocytosis
degree of AT1R among different groups were surveyed under laser scanning confocal
microscope.
Results: Different from ANG II which caused transient contraction of aortic rings
(less than 1 minute), AT1-AA can lead to prolonged contraction of isolated rat aortic
rings (more than 30 minutes); AT1-AA can induce long-lasting intracellular calcium
release in cultured VSMCs (17623s vs. 7319s, P<0.01); endocytosis particles
decreased signiﬁcantly on AT1R transiently expressed HEK293 cells after 10 minutes
of AT1-AA administration.
Conclusions: AT1-AA can lead to reduced AT1R desensitization of rat VSMCs which
is different from ANG II and the possible mechanisms was weakened AT1R endo-
cytosis. Our research will provide in-depth and new perspective for understanding the
pathological features of systemic vasospasm in preeclamptic patients which could
contribute to severe clinical symptoms of both mothers and infants.
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Objectives: Diabetes-induced impairment of collateral formation in ischemic
myocardium has been demonstrated in clinical studies, which may contribute to
unfavorable prognosis among diabetic individuals. However, the underlying
mechanism remains to be deﬁned. In our previous studies, Thioredoxin (Trx) ac-
tivity was shown to be decreased in diabetic cardiac tissues. Thioredoxin-inter-
acting protein (TXNIP), as Trx endogenous inhibitor, is strongly induced by
glucose due to a carbohydrate response element within its promoter. Thus in
present study we aim to determine whether inhibition of Trx by TXNIP exerts a
causative effect on impairment of myocardial ischemia-induced angiogenesis under
diabetic condition and to identify the downstream molecules through in vivo and in
vitro experiments.
Methods: Diabetes was induced by multiple intraperitoneal injections of low-dose
streptozotocin (STZ) in mice. Myocardial infarction (MI) was induced by permanent
occlusion of left anterior descending coronary artery. Small-interfering RNA (siRNA)
targeting TXNIP and recombinant human Trx (rhTrx) was administered intra-
myocardially (4 different sites at the infarct border zone of the left anterior free wall)
and intraperitoneally respectively, immediately after MI. Cardiac function wasJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Bmeasured by echocardiography 30 days after the intervention. The hearts were excised
for immunohistochemical and molecular analysis at predetermined time points. Trx
activity was determined by insulin disulﬁde reduction assay. Human umbilical vein
cord endothelial cells (HUVECs) were treated with or without high glucose medium
for 24 hours. Apoptosis, proliferation, migration and angiogenic capacity of endo-
thelial cells were detected by TUNEL, MTT, Transwell and Matrigel, respectively.
Genes and proteins of interest were detected by Real-time PCR, ELISA, immuno-
precipitation and immunoblotting techniques.
Results: MI-induced myocardial injury was intensiﬁed, evidenced by further
decreased cardiac function and increased ﬁbrosis, along with reduced capillary and
arteriolar density in diabetic mice. Upregulation of TXNIP expression, increased Trx/
TXNIP interaction and reduction of Trx activity were observed in the diabetic heart
before MI and were further ampliﬁed after MI. TXNIP siRNA or rhTrx treatment
counteracted the impairment of angiogenesis and alleviated myocardial ischemic
injury in diabetic mice. In vitro, TXNIP siRNA administration decreased apoptosis,
increased migration activity, and improved angiogenic capacity partly via increase of
VEGF secretion in HUVECs under high glucose stimulation.
Conclusions: Our study demonstrated for the ﬁrst time that TXNIP functions as an
important regulator in diabetes-induced impairment of angiogenesis and thereby
exacerbated myocardial ischemia injury through coordinately targeting Trx in endo-
thelial cells. Blockade of Trx/TXNIP interaction or supplementation of exogenous
rhTrx, might represent avenues for therapeutic exploitation to improve prognosis in
diabetic individuals with coronary artery disease.
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Objectives: Recent studies have revealed the central contribution of alternative
splicing factor (ASF) -regulated calcium/calmodulin-dependent protein kinase IId
(CaMK IId) alternative splicing to pathological cardiac remodeling. ASF can be
phosphorylated by dual-speciﬁcity tyrosine-phosphorylated and regulated kinase 1A
(Dyrk1A). Furthermore, recently we found there is a signaling pathway of Dyrk1A-
ASF-regulated alternative slicing of CaMK IId. Here we aimed to explore whether the
Dyrk1A-ASF-CaMKIId pathway involved in the progression of heart failure in
myocardial infarction rats.
Methods: Myocardial infarction (MI) was induced by ligation of the left anterior
descending coronary artery. Left ventricular internal diameter at end-diastole (LVIDd)
and ejection fraction (EF), fraction shorten (FS) were measured by ultrasound echo-
cardiography. Protein expressions of Dyrk1A and ASF were determined by western
blot, furthermore the phosphorylation of ASF was determined by two-dimension
electropholysis. Alternative splicing of CaMK IId was measured by real-time PCR.
Results: 7 weeks later, we found that MI rats showed an increase in the ratio of left
ventricular weight to heart weight and LVIDd accompanied by a sharply decrease in
EF and FS (P<0.05), which indicated that MI rats had developed signiﬁcant heart
failure. Meantime, Dyrk1A expression and activity were elevated, the phosphorylation
of ASF was increased and there was the dysregulation of CaMK IId alternative
splicing, show as an increase in CaMK IIdA and dC, and a decrease in CaMK IIdB (all
P<0.05) in the MI rats. Conversely, treatment of MI rats with Dyrk1A inhibitor-
Harmine or EGCG effectively attenuated heart failure and reversed the molecular
changes of Dyrk1A, ASF and alternative splicing of CaMKIId caused by MI (all
P<0.05).
Conclusions: Enhanced activation of Dyrk1A-ASF-CaMKIId pathway participate in
heart failure caused by MI. Inhibition the signaling pathway can improve cardiac
function in MI.
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Objectives: Inspired by the effect of resistance to heart failure and Inhibition of
myocardial hypertrophy of astragalus,we proceed to study the possibility of the in-
hibition effect on myocardial remodeling of astragalus. Protein kinase C (protein ki-
nase C, PKC) is the key nodes on the signal transduction pathways of myocardial
hypertrophy, the PKC as research targets is a new way of effective prevention and
control of ventricular remodeling. This study was to explore the effect of astragalus
injection on the adjustment of PKC and impacts on ventricular remodeling in rats after
myocardial infarction.
Methods: 36 Wistar rats were divided into three groups: 12 rats in control group
(SHAM) : intraperitoneal injection of physiological saline 2mL bid6d. Coronary
artery was ligatured except day 7. 12 rats in ischemia reperfusion group (Model) :
intraperitoneal injection of physiological saline 2 mL bid6d. Simple ligatured
IAD in day 7,reperfusion 2h after 30min. 12 rats in astragalus treatment group
(Model + AS) : intraperitoneal injection of astragalus injection 4 g/2ml,bid6 d.
ligatured IAD in day 7,reperfusion 2h after 30min. At 1 week after ligation, we
observed the survival situation of all the rats. The echocardiographic examination
was made to inspect the LVEDD (left ventricular end diastolic diameter), LVESD
(left ventricular end systolic diameter), LVEF (left ventricular ejection fraction) andasic and Translational Medicine C19
